Early antifungal intervention strategies in ICU patients

Current Opinion in Critical Care

Volumn 16, Issue 5, 2010, Pages 465-469

  Eggimann, Philippe ^a   Ostrosky Zeichner, Luis ^b  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Antifungals; Early therapy; Empirical treatment; ICU; Invasive candidiasis

Indexed keywords

ANTIFUNGAL AGENT; BETA 1,3 GLUCAN; CASPOFUNGIN; FLUCONAZOLE;

CLINICAL TRIAL; DISEASE PREDISPOSITION; FUNGAL COLONIZATION; HIGH RISK PATIENT; HUMAN; INTENSIVE CARE UNIT; INVASIVE CANDIDIASIS; NONHUMAN; PROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; SCORING SYSTEM; VALIDATION PROCESS;

ANTIFUNGAL AGENTS; CANDIDIASIS, INVASIVE; HUMANS; INTENSIVE CARE UNITS; PATIENTS;

EID: 78449301995     PISSN: 10705295     EISSN: 15317072     Source Type: Journal    
DOI: 10.1097/MCC.0b013e32833e0487     Document Type: Review

References (38)

1. Morrell M, Fraser V, Kollef MH. Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother 2005; 39:3640-3645.
2. Garey KW, Rege M, Pai MP, et al. Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multiinstitutional study. Clin Infect Dis 2006; 43:25-31.
3. Parkins MD, Sabuda DM, Elsayed S, Laupland KB. Adequacy of empirical antifungal therapy and effect on outcome among patients with invasive Candida species infections. J Antimicrob Chemother 2007; 60:613-618.
4. Pappas PG, Kauffman CA, Andes D, et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 48:503-535.
5. Shorr AF, Chung K, Jackson WL, et al. Fluconazole prophylaxis in critically ill surgical patients: a metaanalysis. Crit Care Med 2005; 33:1928-1935.
6. Playford EG, Webster AC, Sorrell TC, Craig JC. Antifungal agents for preventing fungal infections in nonneutropenic critically ill and surgical patients: systematic review and meta-analysis of randomized clinical trials. J Antimicrob Chemother 2006; 57:628-638.
7. Playford EG, Webster AC, Sorrell TC, Craig JC. Antifungal agents for preventing fungal infections in nonneutropenic critically ill patients. Cochrane Database Syst Rev 2006; CD004920.
8. Cruciani M, de Lalla F, Mengoli C. Prophylaxis of Candida infections in adult trauma and surgical intensive care patients: a systematic review and meta-analysis. Intensive Care Med 2005; 31:1479-1487.
9. Ho KM, Lipman J, Dobb GJ, Webb SA. The use of prophylactic fluconazole in immunocompetent high-risk surgical patients: a meta-analysis. Crit Care 2005; 9:R710-R717.
10. Vardakas KZ, Samonis G, Michalopoulos A, et al. Antifungal prophylaxis with azoles in high-risk, surgical intensive care unit patients: a meta-analysis of randomized, placebo-controlled trials. Crit Care Med 2006; 34:1216-1224.
11. van Till JO, van RO, Lamme B, et al. Single-drug therapy or selective decontamination of the digestive tract as antifungal prophylaxis in critically ill patients: a systematic review. Crit Care 2007; 11:R126.
12. Schuster MG, Edwards JE Jr, Sobel JD, et al. Empirical fluconazole versus placebo for intensive care unit patients: a randomized trial. Ann Intern Med 2008; 149:83-90.
13. Sandven P, Qvist H, Skovlund E, Giercksky KE. Significance of Candida recovered from intraoperative specimens in patients with intra-abdominal perforations. Crit Care Med 2002; 30:541-547.
14. Eggimann P, Garbino J, Pittet D. Management of Candida species infections in critically ill patient. Lancet Infect Dis 2003; 3:772-785.
15. Ostrosky-Zeichner L, Pappas PG. Invasive candidiasis in the intensive care unit. Crit Care Med 2006; 34:857-863.
16. Pittet D, Monod M, Suter PM, et al. Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 1994; 220:751-758.
17. Dupont H, Bourichon A, Paugam-Burtz C, et al. Can yeast isolation in peritoneal fluid be predicted in intensive care unit patients with peritonitis? Crit Care Med 2003; 31:752-757.
18. Paphitou NI, Ostrosky-Zeichner L, Rex JH. Rules for identifying patients at increased risk for candidal infections in the surgical intensive care unit: approach to developing practical criteria for systematic use in antifungal prophylaxis trials. Med Mycol 2005; 43:235-243.
19. Montravers P, DuPont H, Gauzit R, et al. Candida as risk factor in peritonitis. Critical Care Med 2006; 34:646-652.
20. Leon C, Ruiz-Santana S, Saavedra P, et al. A bedside scoring system ('Candida score') for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization. Crit Care Med 2006; 34:730-737.
21. Ostrosky-Zeichner L, Sable C, Sobel J, et al. Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting. Eur J Clin Microbiol Infect Dis 2007; 26:271-276.
22. Preliminary results of a multicenter, international, retrospective, study to validate a clinical prediction rule (CPR) to identify critically-ill patients at risk of invasive candidiasis (IC) for TReatment with Empirical Antifungal Therapy (TREAT Study). Abstracts of the 48th ICAAC, 20-22 October 2008, Chicago, IL; 2008.
23. Charles PE, Castro C, Ruiz-Santana S, et al. Serum procalcitonin levels in critically ill patients colonized with Candida spp: new clues for the early recognition of invasive candidiasis? Intensive Care Med 2009; 35:2146-2150.
24. Ostrosky-Zeichner L, Pappas PG, Shoham S, et al. Improvement of a clinical prediction rule for clinical trials on prophylaxis for invasive candidiasis in the intensive care unit. Mycoses 2009. [E-pub ahead of print] Latest version of the clinical prediction rule.
25. Shorr AF, Tabak YP, Johannes RS, et al. Candidemia on presentation to the hospital: development and validation of a risk score. Crit Care 2009; 13:R156.
26. Solomkin JS, Flohr AB, Quie PG, Simmons RL. The role of Candida in intraperitoneal infections. Surgery 1980; 88:524-530.
27. Saiman L, Ludington E, Dawson JD, et al. Risk factors for Candida species colonization of neonatal intensive care unit patients. Pediatr Infect Dis J 2001; 20:1119-1124.
28. Dubau B, Triboulet S, Winnock S. Utilisation pratique de l'index de colonisation. Ann Fr Anesth Reanim 2001; 20:418-420.
29. Chabasse D. Intérêt de la numeration des levures dans les urines. Revue de la littérature et résultats préliminaires d'une enquête multicentrique réalisée dans 15 centres hospitaliers universitaires. Ann Fr Anesth Reanim 2001; 20:400-406.
30. Garbino J, LewPD, Romand JA, et al. Prevention ofsevere Candida infections in nonneutropenic, high-risk, critically ill patients. A randomized, double-blind, placebo-controlled trial in SDD-treated patients. Intensive Care Med 2002; 28:1708-1717.
31. Charles PE, Doise JM, Quenot JP, et al. Medical and surgical patients difference of outcome between candidemia in critically ill patients. Intensive Care Med 2003; 29:2162-2169.
32. Charles PE, Dalle F, Aube H, et al. Candida spp. colonization significance in critically ill medical patients: a prospective study. Intensive Care Med 2005; 31:393-400.
33. Piarroux R, Grenouillet F, Balvay P, et al. Assessment ofpreemptive treatment to prevent severe candidiasis in critically-ill surgical patients. Crit Care Med 2004; 32:2443-2449.
34. Normand S, Francois B, Darde ML, et al. Oral nystatin prophylaxis of Candida spp. colonization in ventilated critically-ill patients. Intensive Care Med 2005; 31:1466-1468.
35. Agvald-Ohman C, Klingspor L, Hjelmqvist H, Edlund C. Invasive candidiasis in long-term patients at a multidisciplinary intensive care unit: Candida colonization index, risk factors, treatment and outcome. Scand J Infect Dis 2008; 40:145-153.
36. Senn L, Eggimann P, Ksontini R, et al. Caspofungin for prevention of intra-abdominal candidiasis in high-risk surgical patients. Intensive Care Med 2009. [E-pub ahead of print]
37. Faiz S, Neale B, Rios E, et al. Risk-based fluconazole prophylaxis of Candida bloodstream infection in a medical intensive care unit. Eur J Clin Microbiol Infect Dis 2009; 28:689-692.
38. Leon C, Ruiz-Santana S, Saavedra P, et al. Usefulness of the 'Candida score' for discriminating between Candida colonization and invasive candidiasis in nonneutropenic criticallyill patients: a prospective multicenter study. Crit Care Med 2009; 37:1624-1633.